Related references
Note: Only part of the references are listed.Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
James B. Bussel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
Efthymia Vlachaki et al.
HEMATOLOGY REPORTS (2011)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
Connie L. Erickson-Miller et al.
STEM CELLS (2009)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Share Paper
